Live Breaking News & Updates on Company Announces Intent To Separate Oncology Business

Stay updated with breaking news from Company announces intent to separate oncology business. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Alkermes plc Reports Third Quarter 2022 Financial Results

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) today reported financial results for the third quarter of 2022 and updated certain financial expectations for. ....

United States , Katie Joyce , Iain Brown , Sandy Coombs , Janssen Pharmaceutica , Company Announces Intent To Separate Oncology Business , Psych Congress , Drug Administration , Johnson Corporation , Biogen Inc , Company Updates Financial Expectations For , Exchange Commission , Alkermes Inc , Alkermes Pharma Ireland , Acorda Therapeutics Inc , Third Quarter Revenues , Reflect Strong Year Over Growth , Proprietary Commercial Product Portfolio , Company Announces Intent , Separate Oncology Business , Company Updates Financial Expectations , Richard Pops , Chief Executive Officer , Chief Financial Officer , Goods Manufactured , Corporate Responsibility Report ,